Evidence map›Paper›PMID 27829487›Full record

ArticleDiabetic foot & ankle2016

Clinical effectiveness of hemoglobin spray (Granulox

Sharon D Hunt, Fredrik Elg

Open access · bronzeAbstract read
In one paragraph

Article in Diabetic foot & ankle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. A breath of fresh air: the role of oxygen carriers in plastic surgery.Frontiers in bioengineering and biotechnology · 2026
    Review
  3. Exploring New Horizons in Wound Healing: A Comprehensive Analysis.Recent advances in inflammation & allergy drug discovery · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Recent advances in micro-sized oxygen carriers inspired by red blood cells.Science and technology of advanced materials · 2023
    Review
  9. [Research advances on the role of hemoglobin spray in chronic wounds].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Update on management of diabetic foot ulcers.Annals of the New York Academy of Sciences · 2018
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sharon D HuntWellway Medical Group Northumberland, Berwick Upon Tweed, United Kingdom; Sharon.hunt10@nhs.net.
Fredrik ElgPracipio Ltd, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHemoglobin spray (Granulox PATIENTS AND

methodsWound healing outcomes, that is, wound size, pain, percentage of slough, and exudate levels, were compared retrospectively to a similar cohort of patients treated over the same period the previous year. The same inclusion and exclusion criteria applied to both groups.

resultsAll 20 (100%) hemoglobin spray-treated patients and 15 (75%) control patients experienced some wound healing by week 4, with 5 (25%) and 1 (5%), respectively, achieving complete wound closure. At week 4, mean wound size reduction was 63% in the hemoglobin spray group versus 26% for controls, increasing to 95% reduction at week 28 in the hemoglobin spray group versus 63% for controls (

conclusionStandard wound care plus hemoglobin spray results in improvements in wound closure, wound size reduction, pain, slough, and exudate levels compared to control patients for chronic diabetic foot ulcer treatment.

Indexed as

diabetes-related complicationsdiabetic foot ulcerhemoglobintopical oxygen therapywound healing

Identifiers

PMID27829487
PMCPMC5102129
OpenAlexW2550119135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.